Tevogen Bio Holdings Inc. (TVGN) Stock: News, Analysis, Q&A, and Insights

Investment Analysis Report: TVGN

Overview

TVGN is a company in the finance sector, specifically in the industry of Financial Conglomerates. The company has a market capitalization of $1,557,304,629. In this report, we will conduct a comprehensive analysis of TVGN's financial statements over the past three years, focusing on the balance sheets, i...

Technical Analysis of TVGN 2024-04-26

Overview:

In analyzing the technical indicators for TVGN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day MA has been consistently below the closing prices, in...

Recent News & Updates

2024-04-25 21:23
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments(Globenewswire)
2024-04-10 20:05
Tevogen Bio's Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers(Globenewswire)
2024-04-03 08:05
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development(GlobeNewswire)
2024-04-02 20:05
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development(Globenewswire)
2024-03-28 08:05
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price(GlobeNewswire)
2024-03-27 20:05
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price(Globenewswire)
2024-03-26 21:20
Tevogen Bio Announces Series A-1 Preferred Stock Investment(Globenewswire)
2024-03-20 07:00
Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant(Business Wire)
2024-03-05 08:00
Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita(Business Wire)
2024-03-04 19:00
Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita(Businesswire)
2024-02-29 07:42
With a 86% stake, Tevogen Bio Holdings Inc. (NASDAQ:TVGN) insiders have a lot riding on the company(Simply Wall St.)
2024-02-27 16:39
Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI(Business Wire)
2024-02-27 03:39
Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI(Businesswire)
2024-02-21 07:00
Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment(Business Wire)
2024-02-20 18:00
Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment(Businesswire)
2024-02-17 00:17
Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market(Business Wire)
2024-02-16 11:17
Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market(Businesswire)
2024-02-15 09:25
Tevogen Bio Announces $8 Million Equity Investment(Business Wire)
2024-02-14 20:25
Tevogen Bio Announces $8 Million Equity Investment(Businesswire)
2024-02-14 02:55
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGN(Yahoo Finance)
2024-01-31 19:15
Semper Paratus Acquisition Corporation's Shareholders Approve Business Combination with Tevogen Bio(Globenewswire)
2024-01-24 03:05
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq(Globenewswire)
2024-01-04 19:55
Tevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business Combination(Globenewswire)
2023-09-28 20:50
Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement(Globenewswire)
2023-09-14 05:30
Semper Paratus Acquisition CorporationÂ Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc(Yahoo Finance)
2023-06-28 20:05
Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation(Yahoo Finance)

Page 1 of 1

previousnext

TVGN

Performance

Profile